 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, May 1, 2002, 22(9):3352-3358
Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin II
Chia-Jen Siao and Stella E. Tsirka Department of Pharmacological Sciences and Program in Molecular and Cellular Pharmacology, University Medical Center at Stony Brook, Stony Brook, New York 11794
Microglia are the immunocompetent cells of the CNS, and their activation is thought to play an important neurotoxic role in many diseases modeled by glutamate-induced excitotoxicity. One molecule whose expression is upregulated after excitotoxic injury is tissue plasminogen activator (tPA), a serine protease with dual roles in the CNS. The catalytic activity of tPA, which converts plasminogen into plasmin, leads to neuronal death during excitotoxicity. Via a nonproteolytic mechanism, tPA also mediates microglial activation. We show here in culture studies that stimulated wild-type neurons and microglia can release the tPA that elicits the activation, and that tPA acts in combination with other factors. We also show that the finger domain of tPA is necessary to trigger the activation and identify annexin II as its probable binding partner-receptor. Together, these findings suggest that tPA released by either neurons or microglia can act as a neural cytokine, signaling through annexin II to activate microglia in settings of disease and injury. Developing methods to inhibit the interaction of tPA with annexin II would offer a new and selective approach to interfere with microglial activation for therapeutic purposes.
Key words: nonproteolytic; cell signaling; cytokine; receptor; domain deletions; F4/80 glycoprotein
Copyright © 2002 Society for Neuroscience 0270-6474/02/2293352-07$05.00/0
This article has been cited by other articles:
J. J. T. H. Roelofs, K. M. A. Rouschop, G. J. D. Teske, G. T. M. Wagenaar, N. Claessen, J. J. Weening, T. van der Poll, and S. Florquin
Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection
Nephrol. Dial. Transplant., October 8, 2008; (2008) gfn562v1.
[Abstract] [Full Text] [PDF]
F. Adhami, D. Yu, W. Yin, A. Schloemer, K. A. Burns, G. Liao, J. L. Degen, J. Chen, and C.-Y. Kuan
Deleterious Effects of Plasminogen Activators in Neonatal Cerebral Hypoxia-Ischemia
Am. J. Pathol., June 1, 2008; 172(6): 1704 - 1716.
[Abstract] [Full Text] [PDF]
J. J. Sheehan, C. Zhou, I. Gravanis, A. D. Rogove, Y.-P. Wu, D. F. Bogenhagen, and S. E. Tsirka
Proteolytic Activation of Monocyte Chemoattractant Protein-1 by Plasmin Underlies Excitotoxic Neurodegeneration in Mice
J. Neurosci., February 14, 2007; 27(7): 1738 - 1745.
[Abstract] [Full Text] [PDF]
E. V. Ryzhova, R. M. Vos, A. V. Albright, A. V. Harrist, T. Harvey, and F. Gonzalez-Scarano
Annexin 2: a Novel Human Immunodeficiency Virus Type 1 Gag Binding Protein Involved in Replication in Monocyte-Derived Macrophages
J. Virol., March 15, 2006; 80(6): 2694 - 2704.
[Abstract] [Full Text] [PDF]
S. R. Parathath, S. Parathath, and S. E. Tsirka
Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice
J. Cell Sci., January 15, 2006; 119(2): 339 - 349.
[Abstract] [Full Text] [PDF]
K. Tsuji, T. Aoki, E. Tejima, K. Arai, S.-R. Lee, D. N. Atochin, P. L. Huang, X. Wang, J. Montaner, and E. H. Lo
Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral Ischemia
Stroke, September 1, 2005; 36(9): 1954 - 1959.
[Abstract] [Full Text] [PDF]
R. S. Mali, M. Cheng, and S. K. Chintala
Plasminogen activators promote excitotoxicity-induced retinal damage
FASEB J, August 1, 2005; 19(10): 1280 - 1289.
[Abstract] [Full Text] [PDF]
Y. S. Kim, S. S. Kim, J. J. Cho, D. H. Choi, O. Hwang, D. H. Shin, H. S. Chun, M. F. Beal, and T. H. Joh
Matrix Metalloproteinase-3: A Novel Signaling Proteinase from Apoptotic Neuronal Cells That Activates Microglia
J. Neurosci., April 6, 2005; 25(14): 3701 - 3711.
[Abstract] [Full Text] [PDF]
D. Gveric, B. M. Herrera, and M. L. Cuzner
tPA Receptors and the Fibrinolytic Response in Multiple Sclerosis Lesions
Am. J. Pathol., April 1, 2005; 166(4): 1143 - 1151.
[Abstract] [Full Text] [PDF]
X. Wang, K. Tsuji, S.-R. Lee, M. Ning, K. L. Furie, A. M. Buchan, and E. H. Lo
Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke
Stroke, November 1, 2004; 35(11_suppl_1): 2726 - 2730.
[Abstract] [Full Text] [PDF]
V M Diaz, M Hurtado, T M Thomson, J Reventos, and R Paciucci
Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro
Gut, July 1, 2004; 53(7): 993 - 1000.
[Abstract] [Full Text] [PDF]
Y. Iwadate, T. Sakaida, T. Hiwasa, Y. Nagai, H. Ishikura, M. Takiguchi, and A. Yamaura
Molecular Classification and Survival Prediction in Human Gliomas Based on Proteome Analysis
Cancer Res., April 1, 2004; 64(7): 2496 - 2501.
[Abstract] [Full Text] [PDF]
E. H. Lo, J. P. Broderick, and M. A. Moskowitz
tPA and Proteolysis in the Neurovascular Unit
Stroke, February 1, 2004; 35(2): 354 - 356.
[Full Text] [PDF]
C. Brownstein, A. B. Deora, A. T. Jacovina, R. Weintraub, M. Gertler, K. M. F. Khan, D. J. Falcone, and K. A. Hajjar
Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages
Blood, January 1, 2004; 103(1): 317 - 324.
[Abstract] [Full Text] [PDF]
E. S. Roberts, M. A. Zandonatti, D. D. Watry, L. J. Madden, S. J. Henriksen, M. A. Taffe, and H. S. Fox
Induction of Pathogenic Sets of Genes in Macrophages and Neurons in NeuroAIDS
Am. J. Pathol., June 1, 2003; 162(6): 2041 - 2057.
[Abstract] [Full Text] [PDF]
C.-J. Siao, S. R. Fernandez, and S. E. Tsirka
Cell Type-Specific Roles for Tissue Plasminogen Activator Released by Neurons or Microglia after Excitotoxic Injury
J. Neurosci., April 15, 2003; 23(8): 3234 - 3242.
[Abstract] [Full Text] [PDF]
W. Lu, M. Bhasin, and S. E. Tsirka
Involvement of Tissue Plasminogen Activator in Onset and Effector Phases of Experimental Allergic Encephalomyelitis
J. Neurosci., December 15, 2002; 22(24): 10781 - 10789.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|